Viewing Study NCT06389318



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06389318
Status: COMPLETED
Last Update Posted: 2024-05-17
First Post: 2024-04-24

Brief Title: Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Inguinal Hernia Repair
Sponsor: Benha University
Organization: Benha University

Study Overview

Official Title: Comparison Between Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Reducing Parental Separation Anxiety in Children Undergoing Inguinal Hernia Repair A Randomized Clinical Trial
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Inguinal hernia surgery is one of the most common surgical procedures in early infancy Preoperative anxiety remains a vexing issue and it exists in nearly 50 of pediatric patients
Detailed Description: Inguinal hernia surgery is one of the most common surgical procedures in early infancy Preoperative anxiety remains a vexing issue and it exists in nearly 50 of pediatric patients

The administration of sedatives to a child before entering a surgical room is the most common way of reducing the childs distress and allows the child to undergo smooth anesthesia induction

Chloral hydrate is a widely used sedative for young children undergoing imaging studies with a high success rate

Dexmedetomidine is a highly selective alpha-2 agonist for paediatric sedation It produces sedation like natural non-rapid eye movement sleep and has respiratory-sparing effect

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None